• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Acta Otolaryngol . Patterns of self-reported recovery from chemosensory dysfunction following SARS-CoV-2 infection: insights after 1 year of the pa

tetano

Editor, Senior Moderator
Acta Otolaryngol


. Mar-Apr 2022;142(3-4):333-339.
doi: 10.1080/00016489.2022.2062047. Epub 2022 Apr 24.
Patterns of self-reported recovery from chemosensory dysfunction following SARS-CoV-2 infection: insights after 1 year of the pandemic


Dakheelallah M Almutairi[SUP] 1 2 3 [/SUP], Abdulaziz H Almalki[SUP] 1 2 [/SUP], Ahmad A Mirza[SUP] 4 5 [/SUP], Mohammed J Khalifah[SUP] 1 2 [/SUP], Ammar A Aljefri[SUP] 1 2 [/SUP], Khalid A Alsalmi[SUP] 1 2 [/SUP], Majid S Al-Thaqafy[SUP] 1 6 7 [/SUP], Mohammed A Algarni[SUP] 1 2 3 [/SUP]



Affiliations

Abstract

Background: The coronavirus disease (COVID-19), due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causes chemosensory dysfunction.
Aims/objectives: To determine the characteristics of chemosensory dysfunction and to identify factors associated with chemosensory complete recovery and time to recovery.
Materials and methods: This cross-sectional study included all patients presenting with chemosensory dysfunction and confirmed SARS-CoV-2 infection from May to August 2020 who underwent telemedicine follow-up after 1 year to assess their chemosensory recovery.
Results: A total of 372 patients were included, of which 53.8% were male. The mean age ± SD was 37.45 ± 13.44. The majority experienced combined (olfactory and gustatory) dysfunction (85.7%), and 315 patients (84.7%) had complete loss of chemosensory function. The independent predictors associated with a low likelihood of complete recovery were parosmia (aOR 0.16, p < .001), upper respiratory tract symptoms (aOR 0.28, p = .001), and dyspnoea (aOR 0.21, p < .001), whereas the factors associated with a long recovery period were parosmia (aOR 12.04, p = .002), headache (aOR 7.19, p = .007), and hypertension (aOR 7.76, p = .039).
Conclusions: A full recovery outcome was predominant. The presence of parosmia was linked to both an incomplete recovery and a long time to recovery.
Significance: Parosmia and respiratory symptoms are implicated in the incomplete recuperation of chemosensory function.

Keywords: COVID-19; SARS-CoV-2; chemosensory dysfunction; olfactory disorders; taste disorders.
 
Back
Top Bottom